Madrigal Pharmaceuticals (MDGL) EPS (2010 - 2026)
Madrigal Pharmaceuticals (MDGL) EPS from Jun 30, 2010 to Mar 31, 2026. The TTM Madrigal Pharmaceuticals (MDGL) EPS is -$13.59. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Madrigal Pharmaceuticals (MDGL) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -26.73% |
| 3 Years TTM | +29.46% |
| 5 Years TTM | +23.26% |
| 10 Years TTM | +3.04% |
| All Time TTM | -4.98% |
Annual EPS change of Madrigal Pharmaceuticals (MDGL)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$4.10 | -67.54% |
| 2025 | -$12.62 | -40.39% |
| 2024 | -$21.17 | +275.09% |
| 2023 | -$5.64 | +18.96% |
| 2022 | -$4.75 | -66.44% |
| 2021 | -$14.14 | +269.46% |
| 2020 | -$3.83 | +175.20% |
| 2019 | -$1.39 | -34.68% |
| 2018 | -$2.13 | -2.75% |
| 2017 | -$2.19 | -0.84% |
| 2016 | -$2.21 | +27.21% |
| 2015 | -$1.74 | -93.71% |
| 2014 | -$27.61 | -25.38% |
| 2013 | -$37.00 | +16.16% |
| 2012 | -$31.85 | -4.76% |
| 2011 | -$33.44 | +7.43% |
| 2010 | -$31.13 | -138.14% |
| 2009 | $81.60 | N/A |
Comparison Madrigal Pharmaceuticals (MDGL) five years EPS CAGR with competitors
Madrigal Pharmaceuticals (MDGL) five years EPS CAGR is 23.26%.